New hope for fontan hearts: common drug gets special trial
NCT ID NCT07482943
Summary
This study is testing if a drug called dapagliflozin can help people who have had a Fontan heart surgery. It aims to see if the drug improves their ability to exercise and their heart function over three months. The trial will involve about 30 adolescents and adults in Hong Kong who have this specific heart condition.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEART FAILURE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Department of Paediatrics and Adolescent Medicine, Hong Kong Children's Hospital
Hong Kong, Hong Kong
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Queen Mary Hospital
Hong Kong, Hong Kong
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.